COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,637 Articles (22,913 medRxiv, 8,724 bioRxiv)

Most recent first Previous |  Page 1263: Articles 12621-12630  | Next

Personal care formulations demonstrate virucidal efficacy against multiple SARS-CoV-2 variants of concern: implications for hand hygiene
Mukherjee, S., Vincent, C. K., Jayasekera, H. W., Yekhe, A. S.
10.1101/2021.09.20.461073 — Posted: 2021-09-23
An artificial intelligence system for predicting mortality in COVID-19 patients using chest X-rays: a retrospective study
Nanivadekar, A., Zirpe, K., Dwivedi, A., Patel, R., Pant, R., Gupte, T., Lokwani, R., Shende, D., Kulkarni, V., Kharat, A.
10.1101/2021.09.22.21263956 — Posted: 2021-09-23
The impact of heating, ventilation and air conditioning (HVAC) design features on the transmission of viruses, including SARS-CoV-2: an overview of reviews
Thornton, G. M., Kroeker, E., Fleck, B. A., Zhong, L., Hartling, L.
10.1101/2021.09.22.21263515 — Posted: 2021-09-23
Risk factors associated with development and persistence of long COVID
Miyazato, Y., Tsuzuki, S., Morioka, S., Terada, M., Kutsuna, S., Saito, S., Shimanishi, Y., Takahashi, K., Sanada, M., Akashi, M., Kuge, C., Osanai, Y., Tanaka, K., Suzuki, M., Hayakawa, K., Ohmagari, N.
10.1101/2021.09.22.21263998 — Posted: 2021-09-23
Monoclonal antibodies therapy for Covid-19 - Experiences at a regional hospital.
Pannier, J., Nass, N., Behre, G.
10.1101/2021.09.22.21263488 — Posted: 2021-09-23
Consequences of COVID-19 vaccine allocation inequity in Chicago
Zeng, S., Pelzer, K. M., Gibbons, R. D., Peek, M. E., Parker, W. F.
10.1101/2021.09.22.21263984 — Posted: 2021-09-23 Discussion: Onsite
Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer
Parikh, R. B., Takvorian, S. U., Vader, D., Wileyto, E. P., Clark, A. S., Lee, D. J., Goyal, G., Rocque, G. B., Dotan, E., Geynisman, D. M., Phull, P., Spiess, P. E., Kim, R. Y., Davidoff, A. J., Gross, C. P., Neparidze, N., Miksad, R. A., Calip, G. S., Hearn, C. M., Ferrell, W., Shulman, L. N., Mamtani, R., Hubbard, R. A., P.R.A.C.T.I.C.E: Pandemic-Related Advanced Cancer Treatment In the COVID-19 Era
10.1101/2021.09.22.21263964 — Posted: 2021-09-23
Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor
Danziger, O., Patel, R. S., DeGrace, E. J., Rosen, M. R., Rosenberg, B. R.
10.1101/2021.09.22.461286 — Posted: 2021-09-23
Deciphering the role of the Pancreatic Secretome in Covid-19 associated Multi-Organ Dysfunctions
Pathak, E., Mishra, R.
10.1101/2021.09.22.461447 — Posted: 2021-09-23
Two doses of the mRNA BNT162b2 vaccine reduce severe outcomes, viral load and secondary attack rate: evidence from a SARS-CoV-2 Alpha outbreak in a nursing home, Osnabrueck, Germany, January-March 2021
Meyer, E. D., Sandfort, M., Bender, J. K., Matysiak-Klose, D., Doerre, A., Bojara, G., Beyrer, K., Hellenbrand, W.
10.1101/2021.09.13.21262519 — Posted: 2021-09-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).